Acute myocardial infarction market seen reaching $2.06 billion by 2030

The acute myocardial infarction market is projected to grow from $1.56 billion in 2025 to $2.06 billion by 2030, according to The Business Research Company. Rising hypertension, broader use of minimally invasive cardiac care and new diagnostics are among the factors expected to drive demand.

Why it matters: - Acute myocardial infarction, or heart attack, remains a major global health burden, and market growth reflects rising demand for diagnosis, treatment and monitoring tools. - The projected expansion suggests continued investment in cardiac care technologies, from thrombolytic drugs to artificial intelligence-enabled workflows. - Rising hypertension is a direct demand driver because it increases the risk of coronary artery disease and heart attacks.

What happened: - The Business Research Company released The Acute Myocardial Infarction Global Market Report 2026, covering market size, trends and forecasts through 2035. - The acute myocardial infarction market is estimated at $1.56 billion in 2025 and is expected to rise to $1.65 billion in 2026. - The market is forecast to reach $2.06 billion by 2030, implying a 5.7% compound annual growth rate. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

The details: - Historical market growth has been supported by more coronary artery disease cases, expansion of hospitals and specialized cardiac centers, and wider use of electrocardiogram and imaging technologies. - Greater awareness of acute myocardial infarction symptoms has also supported demand. - Increased cardiac research activity has contributed to market growth. - Future growth is expected to come from new thrombolytic drugs, more minimally invasive cardiac procedures and more advanced imaging technologies. - Personalized cardiology treatments and the use of artificial intelligence and big data in cardiac care are also expected to support the market. - Emerging trends include wider acceptance of percutaneous coronary intervention procedures, greater use of advanced cardiac biomarkers for early diagnosis, telecardiology, remote patient monitoring, and prevention programs. - Acute myocardial infarction occurs when blood flow to heart muscle is suddenly reduced or blocked by a coronary artery obstruction, causing myocardial necrosis. - Atherosclerotic plaque rupture is the primary cause. - Hypertension raises the risk of heart disease, stroke and other severe outcomes by damaging arteries, promoting plaque buildup and increasing the chance of coronary clots. - The World Health Organization reported in September 2025 that about 1.4 billion adults aged 30-79 worldwide were living with hypertension in 2024. - That figure represents nearly one-third of the global population in that age group. - The company added new analytical features to its 2026 market reports, including market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future trend analysis, and updated graphics and tables. - The report offers a free sample and full report online through the company’s website: Download a free sample and View the full report.

Between the lines: - The forecast points to a market shaped less by one breakthrough and more by a mix of prevention, early detection and treatment upgrades. - The emphasis on telecardiology, remote monitoring and biomarker-driven diagnosis suggests care is moving earlier in the patient journey and beyond hospital walls. - The regional split indicates mature demand in North America and faster expansion in Asia-Pacific, where healthcare capacity and cardiovascular burden may be rising together.

What's next: - The market will likely track adoption of minimally invasive procedures, advanced diagnostics and digital cardiac care tools. - Growth will also depend on how quickly healthcare systems respond to hypertension and other cardiovascular risk factors. - The report signals more emphasis on data-driven forecasting and market segmentation in future cardiac care research.

The bottom line: - Acute myocardial infarction care is becoming a bigger commercial market as cardiovascular disease rises and treatment technology becomes more advanced.